May Measurement Month (MMM)
MMM
May Measurement Month (MMM26) is a global blood pressure screening campaign aimed at improving awareness, detection, and management of hypertension.
Led by the Centre for Chronic Disease Control (CCDC) in India, the study involves opportunistic screening of adults across multiple healthcare and community settings. By leveraging ongoing CCDC study sites, MMM26 seeks to generate real-world data on blood pressure levels and identify individuals with undiagnosed or uncontrolled hypertension, supporting early intervention and improved cardiovascular health.
Our campaign aims to have a significant impact on the health of our community. By raising awareness about the risks of high blood pressure and providing access to blood pressure measurement. We hope to prevent long-term health complications, such as heart disease and stroke by identifying undiagnosed hypertension and providing guidance on healthy lifestyle.Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast
- Screen at least 1 Lakh individuals during the campaign period for undiagnosed hypertension.
- Provide education to individuals about lifestyle changes that can help prevent and manage high blood pressure
Team Details (PI, Secretariat)
Dr Arun P Jose
Deputy Director & Head - BRIDGE Centre for Digital Health
Dr Hyndavi Salwa
Research Scientist, BRIDGE Centre for Digital Health
Dr Ankur Sharan
Program Associate, BRIDGE Centre for Digital Health
Dr Anvita Gupta
Assistant Manager, BRIDGE Centre for Digital Health
Kasturee Hajra
Research Assistant, BRIDGE Centre for Digital Health
Mr. Mohammed Arish
Sr. Clinical Research Associate, BRIDGE Centre for Digital Health
Project Execution
MMM26 is being implemented as part of a global cross-sectional blood pressure screening campaign conducted across multiple countries. In India, the study is coordinated by CCDC and will be carried out across a wide network of sites, primarily leveraging centres where CCDC studies are currently ongoing. The number and type of participating sites are flexible and may vary during the campaign period.
The study involves opportunistic screening of adults aged 18 years and above who voluntarily participate. Trained staff conduct blood pressure measurements using standardised protocols, ensuring participants are seated and readings are taken in triplicate for accuracy. Along with blood pressure, basic demographic, clinical, and lifestyle information is collected using structured tools.
All data is recorded digitally using secure platforms such as REDCap or standardised spreadsheets, ensuring anonymised and high-quality data collection. Individuals identified with high-normal or elevated blood pressure are provided with immediate lifestyle advice and guidance on seeking further medical care, based on local healthcare facilities.
The campaign is conducted from 1st of May to 31st July 2026. Central monitoring and data validation processes are implemented to maintain data quality and consistency across sites. The collected data is later analysed to generate insights on hypertension prevalence, awareness, and control.
Project’ Potential Impact-
MMM26 has the potential to significantly improve awareness and early detection of hypertension at a population level. By screening large numbers of adults, the study can identify individuals with previously undiagnosed or uncontrolled blood pressure and facilitate timely intervention. The findings will provide valuable evidence to support national and global efforts in strengthening hypertension screening programmes, improving treatment coverage, and reducing the long-term burden of cardiovascular diseases.